These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35791853)

  • 21. Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease.
    Zheng Y; Chou ST
    Clin Lab Med; 2021 Mar; 41(1):101-119. PubMed ID: 33494879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2019.
    Tang AY; Zhou M; Maillis AN; Lai KW; Lane PA; Snyder AB
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30152. PubMed ID: 36579749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bidirectional processes linking social determinants of health and pediatric sickle cell anemia management: A qualitative study.
    Long KA; Blakey AO; Amaro CM; Eilenberg JS; Brochier A; Garg A; Drainoni ML; Pashankar F; Esrick EB; Kavanagh PL
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30539. PubMed ID: 37470711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Experienced Discrimination in Pediatric Sickle Cell Disease: Caregiver and Provider Perspectives.
    Blakey AO; Lavarin C; Brochier A; Amaro CM; Eilenberg JS; Kavanagh PL; Garg A; Drainoni ML; Long KA
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):3095-3106. PubMed ID: 36536165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
    Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
    Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion and sickle cell anemia in Africa.
    Diop S; Pirenne F
    Transfus Clin Biol; 2021 May; 28(2):143-145. PubMed ID: 33515732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health literacy and knowledge of chronic transfusion therapy in adolescents with sickle cell disease and caregivers.
    Yee MEM; Meyer EK; Fasano RM; Lane PA; Josephson CD; Brega AG
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27733. PubMed ID: 30941859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload.
    Koehl B; Missud F; Holvoet L; Ithier G; Sakalian-Black O; Haouari Z; Lesprit E; Baruchel A; Benkerrou M
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caregiver experiences with accessing sickle cell care and the use of telemedicine.
    Jacob SA; Daas R; Feliciano A; LaMotte JE; Carroll AE
    BMC Health Serv Res; 2022 Feb; 22(1):239. PubMed ID: 35193570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
    Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
    Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
    Mazumdar M; Heeney MM; Sox CM; Lieu TA
    Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloimmunization in transfused patients with constitutional anemias in Norway.
    Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
    Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients.
    Sarode R; Matevosyan K; Rogers ZR; Burner JD; Rutherford C
    J Clin Apher; 2011; 26(4):200-7. PubMed ID: 21786315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
    Hilliard LM; Williams BF; Lounsbury AE; Howard TH
    Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.